Hims & Hers: Growth Meets FDA Scrutiny And Tariff Risks [Seeking Alpha]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Seeking Alpha
HIMS stock's premium valuation reflects high growth expectations, leaving little room for missteps amid FDA scrutiny of compounded GLP-1 marketing and new tariff uncertainties. I'm expecting Hims & Hers to see near-term volatility followed by a break as uncertainty around tariffs and the FDA settles. I continue to believe Hims & Hers offers exposure to a booming digital health market and is an attractive pick for investors who can stomach the volatility. I hereon share my sentiment on Hims & Hers stock and why I see more upside ahead. Daniel Grizelj/DigitalVision via Getty Images Investment Thesis Hims & Hers Health, Inc. ( NYSE: HIMS ) stock has been on quite a bullish run. It has managed uncertainties well and was able to overcome the fallout of a partnership with Novo Nordisk ( This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions wit
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- 3 Profitable Stocks for Long-Term Investors [Yahoo! Finance]Yahoo! Finance
- Hims stock falls after lawmakers propose GLP-1 compounding restrictions [Yahoo! Finance]Yahoo! Finance
- Hims & Hers Health (NYSE:HIMS) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.MarketBeat
- Hims & Hers Brings Comprehensive Weight Loss Programme to the UKBusiness Wire
- What Analysts Think Is Changing the Hims and Hers Story for Long Term Investors [Yahoo! Finance]Yahoo! Finance
HIMS
Earnings
- 11/3/25 - Miss
HIMS
Sec Filings
- 12/23/25 - Form 4
- 12/22/25 - Form 144
- 12/18/25 - Form 4
- HIMS's page on the SEC website